Nephrotoxicity

Chairs

Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Matthew Ehrhardt, St. Jude Children’s Research Hospital, Memphis, United States

Coordinator

Esmee Kooijmans, Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Louis S. Constine, University of Rochester Medical Center, Rochester, United States
W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom

WG leaders

Stephen Marks, Great Ormond Street Hospital, London, United Kingdom
Shveta Motwani, Dana-Farber Cancer Institute, Boston, United States
Vesna Pavasovic, Great Ormond Street Hospital, London, United Kingdom
Thomas Walwyn, Perth Children’s Hospital, Nedlands, WA, Australia

WG members

Liv Andres-Jensen, Rigshospitalet, Copenhagen, Denmark
Edit Bardi, Kepler Universitätsklinikum, Linz, Austria and Semmelweis University, Budapest, Hungary
Kerri Becktell, Medical College of Wisconsin/Children’s Hospital of Wisconsin, Wisconsin, United States
Arend Bökenkamp, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands
Charlotte Demoor-Goldschmidt, Centre for Research in Epidemiology and Population Health, Cancer and Radiation team, University of Paris-Sud, Villejuif, France and CHU Angers, France
Daniel Green, St. Jude Children’s Research Hospital, Memphis, United States
Marika Grönroos, Hospital NEO, Turku, Finland
Lars Hjorth, Skåne University Hospital, Lund, Sweden
Kathleen Kieran, Seattle Children’s Hospital, Seattle, United States
Denitza Mironova, UWA Medical Centre Perth, Australia
Ali Mirza Onder, The University of Tennessee Health Science Center, Memphis, United States
Songul Onder, The University of Tennessee Health Science Center, Memphis, United States
Nameeta Richard, Randall Children’s Hospital at Legacy Emanuel Portland, United States
Jonathan Routh, Duke University Medical Center, Duke, United States
Monica Terenziani, Istituto Nazionale Tumori Milano, Italy
Joel Thompson, The Children’s Hospital at OU Medical Center Oklahoma City, United States
Helena van der Pal, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Jakub Zieg, University Hospital Motol, Prague, Czech Republic
Marry M. van den Heuvel-Eibrink, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Margreet Veening, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands